Literature DB >> 9886693

Ethmoid sinus carcinomas: natural history and treatment results.

G L Jiang1, W H Morrison, A S Garden, F Geara, D Callender, H Goepfert, K K Ang.   

Abstract

PURPOSE: This retrospective study was undertaken to assess the clinical features and results of treatment of carcinomas of the ethmoid sinus.
MATERIALS AND METHODS: The records of 34 patients with ethmoid sinus carcinomas treated with curative intent at the U.T.M.D. Anderson Cancer Center (UTMDACC) between January 1969 and December 1993 were reviewed. The age of the patients ranged from 28 to 73 years with a median of 57 years. There were 28 Whites, four Hispanics, one Black and one Asian. A simple staging based on anatomical criteria was used to describe the extent of the disease. Six patients had T1, 13 patients had T2 and 15 patients had T3 disease. Twenty-one patients were treated with surgery plus radiation and 13 patients were treated with radiotherapy alone; nine patients received adjuvant chemotherapy. Radiation was given at approximately 2 Gy per fraction to total doses of 50 Gy preoperatively, 52-66 Gy (median 60 Gy) postoperatively and 50-70 Gy (median 63 Gy) when no surgery was performed.
RESULTS: The actuarial 5-year overall, disease-free and disease-specific survival rates were 55%, 58% and 63%, respectively. The actuarial 5-year local control rate was 71% for the whole group (74% for surgery plus radiation and 64% for radiation alone). Local recurrence occurred in nine patients, nodal relapse occurred in three patients and distant metastases occurred in four patients. Histologically proven dura mater invasion was associated with a poorer local control rate in patients undergoing surgery and radiation. The simple T-staging system used in this study was a good discriminator for local control. Of nine patients receiving chemotherapy, three had complete responses and four had partial responses; six of the seven responders had undifferentiated carcinoma. Severe complications of therapy occurred in patients treated between 1969 and 1984 and consisted mainly of visual impairment and brain necrosis.
CONCLUSIONS: This retrospective review of a large single institutional experience showed that ethmoid sinus carcinomas have a tendency for extensive local invasion but a low propensity for lymphatic and hematogenous spread. Hence, local recurrence was the main cause of cancer-related death. Combined treatment with surgery and postoperative irradiation yielded the highest local control rate. However, radiotherapy alone eradicated two-thirds of primary tumors and, consequently, is a reasonable alternative treatment for patients with medical contraindications to surgery. For patients who underwent surgery and radiotherapy, the presence of histologically proven dura mater invasion was associated with a higher local recurrence rate. Severe radiation complications have been rare with the contemporary radiotherapy technique. Chemotherapy induced excellent responses in undifferentiated carcinoma but its impact on overall disease control is unclear in this small series of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9886693     DOI: 10.1016/s0167-8140(98)00075-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  [Intensity modulated radiotherapy (IMRT) of head and neck tumors. Increased biological effectiveness in high-risk situations by "integrated boost" therapy].

Authors:  D Milanovic; F Lohr; K Götte; B Dobler; B Hermann; K Hörmann; F Wenz
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

2.  Proton beam therapy for locally advanced and unresectable (T4bN0M0) squamous cell carcinoma of the ethmoid sinus: A report of seven cases and a literature review.

Authors:  Takashi Saito; Hitoshi Ishikawa; Kayoko Ohnishi; Teruhito Aihara; Masashi Mizumoto; Nobuyoshi Fukumitsu; Kaori Sugawara; Toshiyuki Okumura; Hideyuki Sakurai
Journal:  Oncol Lett       Date:  2015-05-15       Impact factor: 2.967

3.  Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best?

Authors:  Pauline Castelnau-Marchand; Antonin Levy; Antoine Moya-Plana; Haïtham Mirghani; France Nguyen; Eleonor Rivin Del Campo; François Janot; Frédéric Kolb; François-Régis Ferrand; Stéphane Temam; Pierre Blanchard; Yungan Tao
Journal:  Strahlenther Onkol       Date:  2016-06-20       Impact factor: 3.621

4.  The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation.

Authors:  L Madison Michael; Jeffrey M Sorenson; Sandeep Samant; Jon H Robertson
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

5.  Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma.

Authors:  Giuseppe Lombardi; Fable Zustovich; Alessandro Della Puppa; Lucia Borgato; Enrico Orvieto; Renzo Manara; Diego Cecchin; Franco Berti; Patrizia Farina; Marina Paolo Gardiman; Renato Scienza; Vittorina Zagonel
Journal:  J Neurooncol       Date:  2010-12-08       Impact factor: 4.130

6.  A national series of 244 sinonasal cancers in Finland in 1990-2004.

Authors:  Petri Koivunen; Antti A Mäkitie; Leif Bäck; Matti Pukkila; Jussi Laranne; Ilpo Kinnunen; Kalle Aitasalo; Reidar Grénman
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-18       Impact factor: 2.503

7.  [Principles of radiation therapy for malignant tumors of the orbit and the periorbital area].

Authors:  T Kuhnt; M Janich
Journal:  HNO       Date:  2010-01       Impact factor: 1.284

8.  Endoscopic resection and topical 5-Fluorouracil as an alternative treatment to craniofacial resection for the management of primary intestinal-type sinonasal adenocarcinoma.

Authors:  Simon Mackie; Tass Malik; Hisham Khalil
Journal:  Minim Invasive Surg       Date:  2011-02-16

9.  Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer.

Authors:  Antoine Serre; Katia Idri; Pascal Fenoglietto; Norbert Ailleres; Lore Santoro; Claire Lemanski; Renaud Garrel; Marc Makeieff; Ali Allaw; Jean-Bernard Dubois; David Azria
Journal:  Radiat Oncol       Date:  2007-09-18       Impact factor: 3.481

10.  Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.

Authors:  Vasileios Askoxylakis; Pia Hegenbarth; Carmen Timke; Ladan Saleh-Ebrahimi; Juergen Debus; Falk Röder; Peter E Huber
Journal:  Radiat Oncol       Date:  2016-02-04       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.